Vaccines

Article by GeoVax Labs CSO Featured in The Scientist

Published in AIDS Weekly, May 23rd, 2011

2011 MAY 23 -- To mark HIV Vaccine Awareness Day on May 18, Dr. Harriet L. Robinson, CSO of GeoVax Labs, Inc. (OTCBB: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, has written an article for The Scientist outlining recent progress toward the development of an effective HIV vaccine.

The article, titled "Progress toward an HIV/AIDS vaccine: Recent successes and ongoing efforts to develop a successful vaccine," was published on The Scientist's website on May 11. Dr. Robinson first reviews a collaborative effort based in Thailand that culminated in 2009 with the first encouraging results from an HIV vaccine...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2011-05-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry